发明名称 |
Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases |
摘要 |
An intra-articular pharmaceutical composition is used for the treatment and/or the prevention of acute or chronic osteoarticular diseases and acute or chronic osteoarticular symptoms especially osteoarthritis. The composition includes a possibly adequate pharmaceutical carrier or diluent, a glycosaminoglycan, a compound activating the alpha 2 adrenergic receptor, an anti-inflammatory agent and stem cells. |
申请公布号 |
US9446065(B2) |
申请公布日期 |
2016.09.20 |
申请号 |
US201213625601 |
申请日期 |
2012.09.24 |
申请人 |
BONE THERAPEUTICS |
发明人 |
Bastianelli Enrico;Attali Pierre;Vervaet Chris |
分类号 |
A61K31/728;A61K9/00;A61K31/4168;A61K31/726;A61K45/06;A61K47/36;A61K31/56;A61K35/12;A61K35/545;A61M5/28 |
主分类号 |
A61K31/728 |
代理机构 |
Merchant & Gould P.C. |
代理人 |
Merchant & Gould P.C. |
主权项 |
1. A method for treating a chronic osteoarticular disease in a mammalian subject, the method comprising intra-articularly injecting in a joint of the subject in need thereof a pharmaceutical composition consisting of:
an effective amount of a hyaluronic acid or a derivative thereof; and an effective amount of an alpha 2 adrenergic receptor agonist selected from the group consisting of clonidine and p-aminoclonidine; wherein the pharmaceutical composition reduces joint degeneration and a progress induced by the chronic osteoarticular disease by providing a synergic decrease in articular accumulation of inflammatory liquid, a synergic reduction of joint pain or synergic improvement of joint mobility and function for two weeks or more. |
地址 |
Gosselies BE |